This reflects the Asian nations’ “commitment to bolstering its petrochemical sector, positioning it for sustained dominance ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

Analysis by GlobalData has identified that innovative cardiovascular devices are driving diversification in the growing ...

Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease (TED).

Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...